These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3754510)

  • 1. The distribution of polypeptide YY-like immunoreactivity in rat tissues.
    Miyachi Y; Jitsuishi W; Miyoshi A; Fujita S; Mizuchi A; Tatemoto K
    Endocrinology; 1986 Jun; 118(6):2163-7. PubMed ID: 3754510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide YY-like immunoreactivity in normal colon mucosa, muscle layer and adenocarcinoma.
    Tari A; Miyachi Y; Sumii K; Kajiyama G; Miyoshi A
    Jpn J Med; 1987 May; 26(2):184-8. PubMed ID: 3626157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for regulation of peptide-YY release by the proximal gut.
    Greeley GH; Jeng YJ; Gomez G; Hashimoto T; Hill FL; Kern K; Kurosky T; Chuo HF; Thompson JC
    Endocrinology; 1989 Mar; 124(3):1438-43. PubMed ID: 2917520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility.
    Lundberg JM; Tatemoto K; Terenius L; Hellström PM; Mutt V; Hökfelt T; Hamberger B
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4471-5. PubMed ID: 6956876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
    Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
    Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human distribution and release of a putative new gut hormone, peptide YY.
    Adrian TE; Ferri GL; Bacarese-Hamilton AJ; Fuessl HS; Polak JM; Bloom SR
    Gastroenterology; 1985 Nov; 89(5):1070-7. PubMed ID: 3840109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meal-induced peptide tyrosine tyrosine inhibition of pancreatic secretion in the rat.
    Aponte GW; Park K; Hess R; Garcia R; Taylor IL
    FASEB J; 1989 Jun; 3(8):1949-55. PubMed ID: 2721855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of neurotensin in the canine gastrointestinal tract.
    Doyle H; Greeley GH; Mate L; Sakamoto T; Townsend CM; Thompson JC
    Surgery; 1985 Mar; 97(3):337-41. PubMed ID: 3975854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of peptide YY in the gastrointestinal tract of the rat, dog, and monkey.
    Greeley GH; Hill FL; Spannagel A; Thompson JC
    Regul Pept; 1987 Dec; 19(5-6):365-72. PubMed ID: 3438492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and postprandial release of porcine peptide YY.
    Adrian TE; Bacarese-Hamilton AJ; Smith HA; Chohan P; Manolas KJ; Bloom SR
    J Endocrinol; 1987 Apr; 113(1):11-4. PubMed ID: 3585220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of pancreatic polypeptide-like immunoreactivity in rat tissues.
    Miyazaki K; Funakoshi A
    Regul Pept; 1988 May; 21(1-2):37-43. PubMed ID: 3393693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and immunocytochemical colocalization of peptide YY and enteroglucagon in endocrine cells of the rabbit colon.
    Nilsson O; Bilchik AJ; Goldenring JR; Ballantyne GH; Adrian TE; Modlin IM
    Endocrinology; 1991 Jul; 129(1):139-48. PubMed ID: 1675986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental patterns of glucagon-like peptide-1-(7-36) amide and peptide-YY in rat pancreas and gut.
    Kreymann B; Ghatei MA; Domin J; Kanse S; Bloom SR
    Endocrinology; 1991 Aug; 129(2):1001-5. PubMed ID: 1677327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of peptide YY with rat intestinal epithelial plasma membranes: binding of the radioiodinated peptide.
    Laburthe M; Chenut B; Rouyer-Fessard C; Tatemoto K; Couvineau A; Servin A; Amiranoff B
    Endocrinology; 1986 May; 118(5):1910-7. PubMed ID: 3009142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactive proopiomelanocortin (POMC) peptides and POMC-like messenger ribonucleic acid are present in many rat nonpituitary tissues.
    DeBold CR; Nicholson WE; Orth DN
    Endocrinology; 1988 Jun; 122(6):2648-57. PubMed ID: 2836169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of peptide YY in human brain and pituitary tissues.
    Morimoto R; Satoh F; Murakami O; Totsune K; Saruta M; Suzuki T; Sasano H; Ito S; Takahashi K
    Nutrition; 2008 Sep; 24(9):878-84. PubMed ID: 18662857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactive somatostatin and vasoactive intestinal peptide in the digestive tract of cats.
    Chayvialle JA; Miyata M; Rayford PL; Thompson JC
    Gastroenterology; 1980 Nov; 79(5 Pt 1):837-43. PubMed ID: 6106619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxyntomodulin and glicentin: brain-gut peptides in the rat.
    Blache P; Kervran A; Bataille D
    Endocrinology; 1988 Dec; 123(6):2782-7. PubMed ID: 3197645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut.
    Böttcher G; Sjölund K; Ekblad E; Håkanson R; Schwartz TW; Sundler F
    Regul Pept; 1984 Jul; 8(4):261-6. PubMed ID: 6548568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.
    Kervran A; Blache P; Bataille D
    Endocrinology; 1987 Aug; 121(2):704-13. PubMed ID: 3595539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.